Relationship between dietary folate intake and plasma monocyte chemoattractant protein-1 and interleukin-8 in heart failure patients

Journal of Clinical Biochemistry and Nutrition

Volumn 49, Issue 1, 2011, Pages 62-66

  Chung, Hye Kyung ^a,b   Kim, Oh Yoen ^c   Lee, Hyeran ^a   Do, Hyun Joo ^a   Kim, Young Soon ^a   Oh, Jaewon ^d   Kang, Seok Min ^d   Shin, Min Jeong ^a  

^a Korea University   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Yonsei University   (South Korea)

^d Yonsei University College of Medicine   (South Korea)

Author keywords

Dietary folate; Heart failure; Inflammation; Interleukin 8; MCP 1

Indexed keywords

BETA CAROTENE; C REACTIVE PROTEIN; FOLIC ACID; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1;

ADULT; ARTICLE; DIETARY INTAKE; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; PROTEIN BLOOD LEVEL; QUESTIONNAIRE; RISK FACTOR; VITAMIN INTAKE;

EID: 79959959605     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.10-129     Document Type: Article

References (46)

1. Gullestad L, Aukrust P. The cytokine network in heart failure: pathogenetic importance and potential therapeutic targets. Heart Fai Monit 2001; 2: 8-13.
2. Aukrust P, Ueland T, Lien E, and et al. Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1999; 83: 376-382. (Pubitemid 29066497)
3. Testa M, Yeh M, Lee P, and et al. Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension. J Am Col. Cardiol 1996; 28: 964-971. (Pubitemid 26348163)
4. Torre-Amione G, Kapadia S, Benedict C, Oral H, Young JB, Mann DL. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol 1996; 27: 1201-1206. (Pubitemid 26117714)
5. Kawakami H, Shigematsu Y, Ohtsuka T, and et al. Increased circulating soluble form of Fas in patients with dilated cardiomyopathy. Jpn Circ J 1998; 62: 873-876.
6. Gullestad L, Aukrust P. Review of trials in chronic heart failure showing broad-spectrum anti-inflammatory approaches. Am J Cardiol 2005; 95: C17-C23.
7. Yndestad A, Damås JK, Øie E, Ueland T, Gullestad L, Aukrust P. Role of inflammation in the progression of heart failure. Curr Cardiol Rep 2007; 9: 236-241.
8. Satoh M, Minami Y, Takahashi Y, Nakamura M. Immune modulation: role of the inflammatory cytokine cascade in the failing human heart. Curr Heart Fail Rep 2008; 5: 69-74.
9. Calder PC, Albers R, Antoine JM, and et al. Inflammatory disease processes and interactions with nutrition. Br J Nutr 2009; 101 Suppl: S1-S45.
10. Chen YH, Lin SJ, Chen YL, Liu PL, Chen JW. Anti-inflammatory effects of different drugs/agents with antioxidant property on endothelial expression of adhesion molecules. Cardiovasc Hematol Disord Drug Targets 2006; 6: 279-304.
11. Fischer CP, Hiscock NJ, Penkowa M, and et al. Supplementation with vitamins C and E inhibits the release of interleukin-6 from contracting human skeletal muscle. J Physiol 2004; 558 (Pt2): 633-645.
12. Sluijs I, Beulens JWJ, Grobbee DE, van der Schouw YT. Dietary carotenoid intake is associated with lower prevalence of metabolic syndrome in middleaged and elderly men. J Nutr 2009; 139: 987-992.
13. Rao AV, Rao LG. Carotenoids and human health. Pharmacol Res 2007; 55: 207-216. (Pubitemid 46518154)
14. Liu S, Ajani U, Chae C, Hennekens C, Buring JE, Manson JE. Longterm beta-carotene supplementation and risk of type 2 diabetes mellitus: a randomized controlled trial. JAMA 1999; 282: 1073-1075. (Pubitemid 29436456)
15. Wang L, Liu S, Manson JE, Gaziano JM, Buring JE, Sesso HD. The consumption of lycopene and tomato-based food products is not associated with the risk of type 2 diabetes in women. J Nutr 2006; 136: 620-625. (Pubitemid 43363745)
16. Wang G, Dai J, Mao J, Zeng X, Yang X, Wang X. Folic acid reverses hyperresponsiveness of LPS-induced chemokine secretion from monocytes in patients with hyperhomocysteinemia. Atherosclerosis 2005; 179: 395-402. (Pubitemid 40372213)
17. Witte KK, Nikitin NP, Parker AC, and et al. The effect of micronutrient supplementation on quality-of-life and left ventricular function in elderly patients with chronic heart failure. Eur Heart J 2005; 26: 2238-2244. (Pubitemid 41541386)
18. Shim JS, Oh KW, Suh I, and et al. A study on validity of a semiquantitative food frequency questionnaire of Korean adults. Kor J Community Nutr 2002; 7: 484-494.
19. Lee YC, Lee HJ, Oh KW. Fatty acid composition of Korean foods. Seoul: Shin Kwang Publisher, Inc., 1995.
20. Ministry of Health & Social Welfare, Republic of Korea. Korean food composition table. Seoul: Ministry of Health & Social Welfare, 1996.
21. National Rural Living Science Institute. Food composition table, 5th Revision., 1996.
22. Rimm EB, Willett WC, Hu FB, and et al. Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. JAMA 1998; 279: 359-364. (Pubitemid 28133864)
23. Voutilainen S, Rissanen TH, Virtanen J, Lakka TA, Salonen JT. Low dietary folate intake is associated with an excess incidence of acute coronary events: The Kuopio Ischemic Heart Disease Risk Factor Study. Circulation 2001; 103: 2674-2680. (Pubitemid 32538781)
24. Bazzano LA, He J, Ogden LG, and et al. Dietary intake of folate and risk of stroke in US men and women: NHANES I Epidemiologic Follow-up Study: National Health and Nutrition Examination Survey. Stroke 2002; 33: 1183-1188. (Pubitemid 34517031)
25. Drogan D, Klipstein-Grobusch K, Dierkes J, Weikert C, Boeing H. Dietary intake of folate equivalents and risk of myocardial infarction in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study. Public Health Nutr 2006; 9: 465-471. (Pubitemid 44125265)
26. Solini A, Santini E, Ferrannini E. Effect of short-term folic acid supplementation on insulin sensitivity and inflammatory markers in overweight subjects. Int J Obes (Lond) 2006; 30: 1197-1202. (Pubitemid 44141607)
27. Title LM, Cummings PM, Giddens K, Genest JJ Jr., Nassar BA. Effect of folic acid and antioxidant vitamins on endothelial dysfunction in patients with coronary artery disease. J Am Coll Cardiol 2000; 36: 758-765.
28. Au-Yeung KK, Yip JC, Siow YL, O K. Folic acid inhibits homocysteine-induced superoxide anion production and nuclear factor kappa B activation in macrophages. Can J Physiol Pharmacol 2006; 84: 141-147. (Pubitemid 44017619)
29. Vasan RS, Beiser A, D'Agostino RB, and et al. Plasma homocysteine and risk for congestive heart failure in adults without prior myocardial infarction. JAMA 2003; 289: 1251-1257. (Pubitemid 37432905)
30. Jacques PF, Bostom AG, Wilson PW, Rich S, Rosenberg IH, Selhub J. Determinants of plasma total homocysteine concentration in the Framingham Off-spring cohort. Am J Clin Nutr 2001; 73: 613-621. (Pubitemid 32176514)
31. Kennedy RH, Owings R, Shekhawat N, Joseph J. Acute negative inotropic effects of homocysteine are mediated via the endothelium. Am J Physiol Heart Cir Physiol 2004; 287: H812-H817. (Pubitemid 38955317)
32. Joseph J, Washington A, Joseph L, and et al. Hyperhomocysteinemia leads to adverse cardiac remodeling in hypertensive rats. Am J Physiol Heart Circ Physiol 2002; 283: H2567-H2574. (Pubitemid 35345964)
33. Poddar R, Sivasubramanian N, Dibello PM, Robinson K, Jacobsen DW. Homocysteine induces expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human aorticendothelial cells implications for vascular disease. Circulation 2001; 103: 2717-2723. (Pubitemid 32538788)
34. Wang G, Siow YL, O K. Homocysteine induces monocyte chemoattractant protein-1 expression by activating NF-κB in THP-1 macrophages. Am J Physiol Heart Circ Physiol 2001; 280: H2840-2847.
35. van Aken, Jansen J, van Deventer SJ, Reitsma PH. Elevated levels of homocysteine increase IL-6 production in monocytic Mono Mac 6 cells. Blood Coagul Fibrinolysis 2000; 11: 159-164. (Pubitemid 30212856)
36. Alp NJ, Channon KM. Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease. Arterioscler Thromb Vasc Biol 2004; 24: 413-420. (Pubitemid 38326132)
37. Hyndman ME, Verma S, Rosenfeld RJ, Anderson TJ, Parsons HG. Interaction of 5-methyltetrahydrofolate and tetrahydrobiopterin on endothelial function. Am J Physiol Heart Circ Physiol 2002; 282: H2167-H2172. (Pubitemid 34663027)
38. Joshi R, Adhikari S, Patro BS, Chattopadhyay S, Mukherjee T. Free radical scavenging behavior of folic acid: evidence for possible antioxidant activity. Free Radic Biol Med 2001; 30: 1390-1399. (Pubitemid 32522954)
39. Stroes ES, van Faassen EE, Yo M, and et al. Folic acid reverts dysfunction of endothelial nitric oxide synthase. Circ Res 2000; 86: 1129-1134. (Pubitemid 30396037)
40. Yu R, Kim CS, Kawada T, and et al. Involvement of leukotactin-1, a novel CC chemokine, in human atherosclerosis. Atherosclerosis 2004; 174: 35-42. (Pubitemid 38595437)
41. Zozuliñska D, Majchrzak A, Sobieska M, Wiktorowicz K, Wierusz-Wysocka B. Serum interleukin-8 level is increased in diabetic patients. Diabetologia 1999; 42: 117-118. (Pubitemid 29039749)
42. Dominguez-Rodriguez A, Abreu-Gonzalez P, Garcia-Gonzalez M, Ferrer J. Prognostic value of interleukin-8 as a predictor of heart failure in patients with myocardial infarction and percutaneous intervention. Int J Cardiol 2006; 111: 158-160. (Pubitemid 44107526)
43. Friso S, Jacques PF, Wilson PW, Rosenberg IH, Selhub J. Low circulating vitamin B(6) is associated with elevation of the inflammation marker Creactive protein independently of plasma homocysteine levels. Circulation 2001; 103: 2788-2791.
44. Folsom AR, Desvarieux M, Nieto FJ, Boland LL, Ballantyne CM, Chambless LE. B vitamin status and inflammatory markers. Atherosclerosis 2003; 169: 169-174. (Pubitemid 36830936)
45. Dusitanond P, Eikelboom JW, Hankey GJ, and et al. Homocysteinelowering treatment with folic acid, cobalamin, and pyridoxine does not reduce blood markers of inflammation, endothelial dysfunction, or hypercoagulability in patients with previous transient ischemic attack or stroke: a randomized substudy of the VITATOPS trial. Stroke 2005; 36: 144-146. (Pubitemid 40054191)
46. Peeters AC, van Aken BE, Blom HJ, Reitsma PH, den Heijer M. The effect of homocysteine reduction by B-vitamin supplementation on inflammatory markers. Clin Chem Lab Med 2007; 45: 54-58. (Pubitemid 46155560)